RxDoctor Payments Data

David Harwood, MD

Orthopaedic Surgery · Somerset, NJNPI 1144225079

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $26,006 of the $36,890 with a category attached, or 70.5%. Smith+Nephew accounts for 98.6% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $18,719 and has fallen 99.5% since, to $95 in 2025.

$36,890in general payments, 2019–2025

Across 31 payments — averaging $1190.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$36K
  • Johnson & Johnson$171
  • Zimmer Biomet$122
  • KCI USA, Inc.$97
  • Biocomposites Inc$75
  • Bioventus LLC$26
  • plus $19 from 1 others
$26,238in research payments, 2019–2025

Across 12 payments — averaging $2186.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Smith+Nephew$26K

What the payments were for

  • Consulting fees$26,00670%
  • Speaking & faculty fees$7,57021%
  • Travel & lodging$2,4437%
  • Food & beverage$8712%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$36,890 in reported general payments places this provider in the 85th percentile of 587 orthopaedic surgery providers in New Jersey.

See all orthopaedic surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$361,712
Medicare patients
578
Services billed
4,034

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Amoxicillin28$40
Tramadol Hcl14$27

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Somerset

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →